Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30
United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jean Jacques Bienaime
5 Jun 2026
Director
Buy
1,000
$19.27
$19.27K
Jean Jacques Bienaime
5 Jun 2026
Director
Buy
3,500
$19.46
$68.11K
Jean Jacques Bienaime
5 Jun 2026
Director
Buy
6,000
$19.48
$116.88K
Jean Jacques Bienaime
15 May 2026
Director
Buy
5,000
$20.70
$103.50K
Clay B Siegall
27 Mar 2026
President and CEO
Buy
25,450
$19.67
$500.60K
Jean Jacques Bienaime
11 Mar 2026
Director
Buy
1,000
$21.55
$21.55K
Jean Jacques Bienaime
10 Mar 2026
Director
Buy
1,000
$22.12
$22.12K
Clay B Siegall
30 Dec 2025
President and CEO
Buy
4,729
$21.15
$100.02K
Philip Tsai
19 Dec 2025
Chief Technical Officer
Buy
10,000
$20.49
$204.90K
Clay B Siegall
19 Dec 2025
President and CEO
Buy
7,278
$20.48
$149.05K
Clay B Siegall
18 Dec 2025
President and CEO
Buy
46,511
$21.50
$999.99K

What was left out

Form 4 filings counted 37
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 11
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 999,610
History held since 5 Oct 2020